]>
IRCT20170705034915N2 IRCT 2019-02-06 MIM Daroo Pharmaceutical Co. Investigation of AllergyCut therapeutic effect of Allergic Rhinitis patients Investigation of Effectiveness of AllergyCut on Reducing the Severity and intensity of Disease in Allergic Rhinitis Patients 2018-04-04 anticipated 75 Complete https://irct.ir/trial/26556 interventional Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Treatment. 2-3 Rhinitis Allergy. Intervention 1: Intervention group: Patients with allergic rhinitis: Use of AllergyCut contains distilled plant product intended to remove symptoms of allergic rhinitis for 120 days with permissible dose every 6 hours 1 puff per nasal cavity. Intervention 2: Control group: Patients with allergic rhinitis: whiteout any treatment. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no further information
public Farid Semsarha
No. 4, 4th Street, Ganbarzadeh Street, Shahid Beheshti Street, Tehran, Iran
Tehran Iran (Islamic Republic of) 1533754716 +98 21 9662 1410 fsemsarha@mimdaroo.com MIM Daroo scientific Farid Semsarha
No. 4-4th alley- Eshghyar street-Ghanbarzadeh st.-Beheshti Ave.-Terhan-Iran
Tehran Iran (Islamic Republic of) 1533853613 +98 21 9662 1410 fsemsarha@mimdaroo.com MIM daroo Pharmaceutical Co. Iran (Islamic Republic of) Patients with Rhinitis after diagnosis by an immunologist or ENT physician Male and female patient who has symptoms of allergic rhinitis at least one month per year. A patient aged over 16 years old up to 60 years old who has the opportunity to complete the day care and has an effective relationship with the counselor. A patient who does not have allergy to herbal medicines. no limit no limit Both Patient with rhinitis without diagnosis of immunological basis. Patients who do not want to start or continue treatment are not eligible for study. Patients who provide incomplete data to the counselor. J30.4 Allergic rhinitis, unspecified Treatment - Drugs Other Intervention group: Patients with allergic rhinitis: Use of AllergyCut contains distilled plant product intended to remove symptoms of allergic rhinitis for 120 days with permissible dose every 6 hours 1 puff per nasal cavity. Control group: Patients with allergic rhinitis: whiteout any treatment Reduced Indicators Related to Rhinitis in Patients Consuming the Drugs. Timepoint: Drug intakes for 60 to 120 days. Method of measurement: Study of allergy-related rhinitis allergy indexes under the supervision of an immunologist. MIM Daroo Pharmaceutical Co. Approved 2018-05-13 Ethics committee of azad University-Research and science branch Iran, Tehran, Ghods Town, Between South Falamak and Zarafshan, Iran Simay Avenue, Central Headquarters of the Ministry of Health Education, Unit A, Floor 13 Tehran Tehran Iran (Islamic Republic of)